image_alt_text
8

Joseph R. Moskal, Ph.D.

AIMBE College of Fellows Class of 2017
For studies of the NMDA receptor have led to the design and development of novel therapeutics for the treatment of depression.

Joseph Moskal Receives Top Biotechnology Innovator Award

Via Northwestern University | October 3, 2017

Northwestern Engineering professor Joseph Moskal has received the iCON Innovator Award from the Illinois Biotechnology Innovation Organization (iBIO), an industry association of more than 200 companies, academic institutions, and service providers dedicated to making Illinois and the Midwest a leader in life sciences ventures and technology.

The iCON Innovator Award recognizes an active researcher within the ranks of life sciences education who is acknowledged by his or her peers as a leader in the contemporary teaching of, and scholarship in, biotechnology and its related sciences. Moskal will formally accept the award during the iBIO iCON Awards dinner on October 3 at The Field Museum.

“This feels like a lifetime achievement award. We have been in Chicago trying to develop novel therapeutics for brain disorders for almost 30 years,” Moskal said. “Perhaps as important, iBIO stresses education and mentoring, which has been an integral part of our vision. I am truly and deeply honored by this award… Continue reading.

Joseph R. Moskal, Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 1, 2017

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Joseph R. Moskal, Ph.D., Distinguished Research Professor, Department of Biomedical Engineering, McCormick School of Engineering and Applied Sciences, Northwestern University, to its College of Fellows. Dr. Moskal was nominated, reviewed, and elected by peers and members of the College of Fellows For studies of the NMDA receptor have led to the design and development of novel therapeutics for the treatment of depression..